Cross NC - Search Results

1

Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.

White HE, Hedges J, Bendit I, Branford S, Colomer D, Hochhaus A, Hughes T, Kamel-Reid S, Kim DW, Modur V, Müller MC, Pagnano KB, Pane F, Radich J, Cross NC, Labourier E. White HE, et al. Among authors: cross nc. Clin Chem. 2013 Jun;59(6):938-48. doi: 10.1373/clinchem.2012.196477. Epub 2013 Mar 7. Clin Chem. 2013. PMID: 23471097 Free article.

2

Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.

Hochhaus A, Lin F, Reiter A, Skladny H, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Br J Haematol. 1995 Sep;91(1):126-31. doi: 10.1111/j.1365-2141.1995.tb05257.x. Br J Haematol. 1995. PMID: 7577619

3

Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.

van Rhee F, Marks DI, Lin F, Szydlo RM, Hochhaus A, Treleaven J, Delord C, Cross NC, Goldman JM. van Rhee F, et al. Among authors: cross nc. Leukemia. 1995 Feb;9(2):329-35. Leukemia. 1995. PMID: 7869772

4

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.

Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM. Cross NC, et al. Blood. 1993 Sep 15;82(6):1929-36. Blood. 1993. PMID: 8400243 Free article.

5

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.

Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Blood. 1996 Feb 15;87(4):1549-55. Blood. 1996. PMID: 8608246 Free article.

6

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC. van Rhee F, et al. Among authors: cross nc. Blood. 1996 Jun 15;87(12):5213-7. Blood. 1996. PMID: 8652835 Free article.

7

Quantitative molecular methods to monitor the response of CML patients to interferon-alpha.

Hochhaus A, Lin F, Reiter A, Skladny H, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Bone Marrow Transplant. 1996 May;17 Suppl 3:S41-4. Bone Marrow Transplant. 1996. PMID: 8769700

8

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Blood. 1996 Sep 15;88(6):2236-40. Blood. 1996. PMID: 8822944 Free article.

9

Molecular investigation of secondary chronic myeloid leukemia.

Aguiar RC, Sill H, Hochhaus A, Goldman JM, Cross NC. Aguiar RC, et al. Among authors: cross nc. Blood. 1996 Oct 1;88(7):2808-9. Blood. 1996. PMID: 8839881 Free article. No abstract available.

10

Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia.

Carapeti M, Soede-Bobok A, Hochhaus A, Sill H, Touw IP, Goldman JM, Cross NC. Carapeti M, et al. Among authors: cross nc. Leukemia. 1997 Jul;11(7):1005-8. doi: 10.1038/sj.leu.2400697. Leukemia. 1997. PMID: 9204982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters